Published 2011
| Version v1
Publication
A case of thyroiditis during natalizumab therapy for multiple sclerosis
Contributors
Description
This clinical observation indicates that thyroid function needs to be monitored during therapy with natalizumab, as with other biological medicines, and that thyroid volume and antibody modulation are predictive factors of functional evolution during and after treatment.
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/280668
- URN
- urn:oai:iris.unige.it:11567/280668
Origin repository
- Origin repository
- UNIGE